The Evolving Role of Nutrition Therapy in the Hospitalized Patient: Focus on Lipids and Protein

Released On
December 11, 2019

Expires On
December 11, 2020

Media Type
Internet

Completion Time
45 minutes

Specialty
Critical/Intensive Care, Fluid Management, Geriatrics, Intensivist, Nursing, Nutrition, Pharmacy, Surgery, Trauma

Topic(s)
Nutrition Therapy

Scroll to the Bottom of this Information to Begin this Course

Sponsored by The Academy for Continued Healthcare Learning (ACHL).

 

Supported by an educational grant from Baxter Healthcare Corporation.

Credit Available

  • Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)
  • Dietitians — 1.0 CDR Continuing Professional Education unit.

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for physicians, pharmacists, nurses and dietitians who manage clinical nutrition.

Program Overview

New research has provided evidence of the complexity of a patient’s nutritional needs during hospitalization. As our understanding of nutrition in hospitalized patients expands, the importance of tailoring nutritional therapies to the individual becomes more apparent. Further, new and emerging products for lipid emulsion and protein delivery are available. Updating clinicians on the many recent changes to nutritional therapy in the hospital is essential to aid patients in achieving their nutritional goals.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain new standard diagnostic criteria for malnutrition outlined by the Global Leadership Initiative on Malnutrition (GLIM) and how it applies to clinical practice
  • Interpret available outcome data on new lipid emulsion products and how the differences in fatty acid profiles of new products may influence inflammation
  • Discuss how high vs. standard protein delivery may benefit hospitalized patients, particularly in the ICU
  • Compare and contrast newly available and emerging macronutrient parenteral nutrition products, and describe how these new products can aid in improving nutrition therapy for hospitalized patients

Faculty

Johane P. Allard, MD, FRCPC

Professor of Medicine
Department of Medicine, Gastroenterology
University of Toronto
Toronto General Hospital
Toronto, Ontario, Canada

Manpreet S. Mundi, MD

Associate Professor of Medicine
Medical Director, Home Enteral Nutrition Program
Mayo Clinic College of Medicine and Science
Rochester, Minnesota

Juan B. Ochoa Gautier, MD, FACS

Professor of Surgery
Ochsner Health System
New Orleans, Louisiana

Continuing Medical Education

Accreditation Statement

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

The Academy for Continued Healthcare Learning is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 1.0 Continuing Professional Education units (CPEUs) for completion of this activities/materials. Level 2. CDR Accredited Provider #AC001.

RDs and DTRs may submit additional evaluations of the quality of this program/material at www.cdrnet.org.

The activity number for this activity is 151733.

Disclosures of Conflicts of Interest

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

The following financial relationships have been provided:

Manpreet Mundi, MD

  • Research Support: Fresenius Kabi, Nestle Heath Science, Real Food Blends

The following faculty have no relevant financial relationships to disclose:

  • Johane Allard, MD, FRCP
  • Juan Ochoa Gautier, MD, FACS

Staff Disclosures

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Instructions for Participation and Credit

This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pre-test, view the online activity, and complete the post-test and evaluation. To receive credit, 80% must be achieved on the post-test. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions about this activity, please contact Katlyn Cooper at kcooper@achlcme.org.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.

Disclosure of Unlabeled Use

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Parenteral nutrition products available outside the United States.

Disclaimer

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.